```html

Junctional Cardiac Defect (Atrioventricular Septal Defect) – A Patient‑Friendly Guide

Overview

Junctional cardiac defect (JCD) is another name for an atrioventricular septal defect (AVSD), a congenital heart malformation that involves the septum (wall) between the heart’s chambers and the atrioventricular (AV) valves. In a typical heart, the atrial septum separates the right and left atria, the ventricular septum separates the right and left ventricles, and the mitral and tricuspid valves control blood flow from atria to ventricles. In AVSD, part of these structures is missing or malformed, creating a “hole” at the junction of the atria and ventricles and often causing the valve leaflets to be shared between the two sides.

AVSDs are classified into three main types:

• Partial (or “incomplete”) AVSD – an atrial septal defect (ASD) with a common AV valve that functions mostly like a normal mitral valve.
• Complete AVSD – both an atrial and ventricular septal defect (VSD) plus a common AV valve that straddles both ventricles.
• Intermediate AVSD – features of both partial and complete types (large ASD with a small VSD).

Who is affected? AVSD is a congenital condition, meaning it is present at birth. It accounts for roughly 4–5% of all congenital heart defects and is the most common cyanotic heart defect in patients with Down syndrome (trisomy 21). Overall prevalence is estimated at 1 in 6,000–10,000 live births worldwide.<sup>1</sup>

Both males and females are affected equally, but because of its strong association with Down syndrome, families with a child who has this chromosomal condition are at higher risk.

Symptoms

Symptoms vary with the size of the defect, the type of AVSD, and the age of the patient. Newborns may appear well initially, while larger defects can cause early heart failure. Below is a comprehensive list of possible signs, grouped by age.

Neonates (first weeks of life)

• Rapid breathing (tachypnea) – lungs work harder to receive enough oxygen.
• Feeding difficulties – fatigue, poor weight gain, or needing to eat frequently.
• Bluish skin (cyanosis) – especially during feeding or exertion, due to mixing of oxygen‑poor and oxygen‑rich blood.
• Heart murmur – a soft, “holosystolic” or “rumbling” murmur heard over the lower left sternal border.
• Excessive sweating – especially during feeds.
• Enlarged liver or abdomen – sign of congestion from heart failure.

Infants and toddlers (0‑3 years)

• Failure to thrive (weight below the 5th percentile).
• Shortness of breath with minimal activity.
• Frequent respiratory infections or pneumonia.
• Wheezing or “wet” cough due to pulmonary congestion.
• Continued or new heart murmur.

Older children and adolescents

• Exercise intolerance – getting tired quickly during play or sports.
• Palpitations or irregular heartbeat (atrial arrhythmias are common).
• Chest pain (rare, usually due to strain).
• Persistent cyanosis or “blue fingers/toes”.

Adults

• Progressive fatigue and shortness of breath.
• Signs of heart failure (edema, orthopnea).
• Arrhythmias (atrial fibrillation, flutter).
• Increased risk of infective endocarditis.

Because symptoms can be subtle, routine pediatric examinations and newborn screening are essential for early detection.

Causes and Risk Factors

AVSD results from abnormal development of the endocardial cushions—structures that form the atrial septum, part of the ventricular septum, and the AV valves during weeks 5‑8 of gestation. When these cushions fail to fuse properly, the septal defects and valve anomalies appear.

Genetic and Chromosomal Factors

• Down syndrome (trisomy 21) – present in 40‑80% of AVSD cases.<sup>2</sup>
• Other chromosomal abnormalities – e.g., trisomy 13, 18, Turner syndrome.
• Single‑gene mutations – rare mutations in the NKX2‑5, GATA4, or CRELD1 genes have been linked to AVSD.

Environmental Risks

• Maternal diabetes (especially uncontrolled pre‑gestational diabetes).
• Maternal exposure to alcohol, certain medications (e.g., isotretinoin), or illicit drugs during the first trimester.
• Maternal infections (e.g., rubella) that affect early heart development.

Family History

If a close relative has a congenital heart defect, the recurrence risk rises to about 1–2% (still low but higher than the general population).

Diagnosis

Early diagnosis improves outcomes. A combination of physical exam findings, imaging, and sometimes genetic testing is used.

Physical Examination

• Detection of a heart murmur.
• Signs of cyanosis, poor growth, or heart failure.

Imaging Studies

• Echocardiography (transthoracic echo) – the gold‑standard test. It shows the size and location of the septal defects, valve morphology, and blood flow patterns using Doppler. It can differentiate partial, complete, and intermediate AVSD.
• Fetal echocardiography – can diagnose AVSD as early as 18–22 weeks gestation, especially in pregnancies with known Down syndrome.
• Cardiac MRI or CT – used when echo images are limited (e.g., in older children with acoustic windows). Provides detailed anatomy of the AV valves and surrounding vessels.

Electrocardiogram (ECG)

• May show signs of atrial enlargement, left‑axis deviation, or arrhythmias.

Cardiac Catheterization

• Rarely needed for diagnosis but sometimes performed to assess pulmonary artery pressures (especially before surgery) or to intervene on associated lesions.

Genetic Testing

• Karyotype analysis or chromosomal microarray is recommended when Down syndrome or other chromosomal abnormalities are suspected.
• Targeted gene panels for congenital heart disease can be considered in families with a known gene mutation.

Treatment Options

The goal of treatment is to close the septal defects, restore normal valve function, and prevent heart failure or pulmonary hypertension.

Medical Management (Pre‑operative)

• Diuretics (e.g., furosemide) – reduce pulmonary congestion.
• ACE inhibitors or ARBs – lower systemic vascular resistance and help heart remodeling.
• Beta‑blockers – control heart rate if tachyarrhythmias develop.
• Prophylactic antibiotics – recommended before dental or invasive procedures to prevent infective endocarditis (American Heart Association guidelines).

Surgical Repair

Most children with a complete or large partial AVSD need surgical correction between 3–6 months of age, before irreversible pulmonary vascular disease develops.

• Standard repair – closes the ASD and VSD with patches and reconstructs two separate AV valves (mitral and tricuspid). The “single‑leaflet” valve is divided and fashioned into two functional valves.
• Patch material – autologous pericardium, synthetic patches, or bovine/porcine tissue.
• Outcomes – Survival >90% in modern series; most patients achieve normal or near‑normal activity levels.<sup>3</sup>

Catheter‑Based Interventions

• Rarely used for AVSD because the defect involves valve tissue, but in selected partial defects with a restrictive VSD, device closure may be considered.

Post‑operative Care

• Intensive monitoring for low cardiac output, arrhythmias, or residual shunts.
• Gradual re‑introduction of feeds and activity.
• Long‑term follow‑up with a pediatric cardiologist (often lifelong).

Lifestyle & Long‑Term Management

• Regular cardiovascular exercise as tolerated (guidance from cardiology).
• Vaccinations – flu and pneumococcal vaccines to reduce respiratory infections.
• Avoidance of illicit drugs and nicotine, which can raise pulmonary pressures.

Living with Junctional Cardiac Defect (Atrioventricular Septal Defect)

Even after successful repair, many patients lead active, healthy lives. Below are practical tips for daily management.

Routine Monitoring

• Cardiology visits every 6–12 months during childhood; annually in adulthood if no residual lesions.
• Electrocardiograms and echocardiograms at each visit to check valve function and heart size.
• Blood pressure checks – maintain systolic < 130 mm Hg.

Activity & Exercise

• Most children can participate in normal school activities and sports after surgeon clearance (usually 6–12 weeks post‑op).
• Avoid high‑intensity competitive sports if moderate/severe valve regurgitation or residual shunt persists.
• Encourage aerobic activities like swimming, biking, or walking.

Nutrition & Growth

• Breastfeeding or high‑calorie formulas for infants with feeding fatigue.
• Balanced diet rich in fruits, vegetables, whole grains, lean proteins, and low sodium.
• Monitor weight gain; any plateau >2 weeks warrants a medical review.

Psychosocial Support

• Connect with congenital heart disease (CHD) support groups for families.
• Address anxiety related to medical appointments or procedures with counseling if needed.
• Educational accommodations may be required for children with frequent medical appointments.

Medication Adherence

• Use pill organizers or alarms.
• Keep a medication list up‑to‑date and share it with all healthcare providers.

Pregnancy Considerations (for women with repaired AVSD)

• Pre‑conception cardiology evaluation is essential.
• Most women with a successful repair and normal valve function tolerate pregnancy well, but they require close monitoring for arrhythmias or heart failure.

Prevention

Because AVSD is congenital, primary prevention is limited, but steps can lower the risk of associated heart defects.

• Pre‑conception counseling – especially for couples where one partner has Down syndrome or a known genetic mutation.
• Optimize maternal health – control diabetes, avoid smoking and alcohol, and manage medications under a physician’s guidance.
• Folate supplementation – 0.4 mg daily before conception and through the first trimester reduces many congenital anomalies (although specific impact on AVSD is modest).
• Vaccination – rubella vaccination before pregnancy prevents rubella‑associated cardiac defects.
• Prenatal screening – detailed fetal ultrasound and, when indicated, fetal echocardiography can identify AVSD early, allowing for parental counseling and delivery planning at a tertiary center.

Complications

If left untreated or if residual lesions persist after repair, several serious complications can arise:

• Pulmonary hypertension – high pressure in lung vessels can become irreversible (Eisenmenger syndrome) and is life‑threatening.
• Heart failure – due to volume overload from left‑to‑right shunt or valve regurgitation.
• Arrhythmias – atrial fibrillation, atrial flutter, or complete heart block, especially after surgery.
• Valve dysfunction – residual mitral or tricuspid regurgitation may need re‑operation in 10–15% of patients.
• Infective endocarditis – risk is higher in patients with valve abnormalities; prophylaxis reduces risk.
• Stroke – rare but can occur from emboli due to atrial arrhythmias or paradoxical embolism.
• Re‑operation – Approximately 5–10% of repaired patients require a second surgery later in life for valve repair or residual defects.

When to Seek Emergency Care

---

References:
1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890‑1900.
2. American Heart Association. Down syndrome and congenital heart disease. Circulation. 2020.
3. Jacobs JP, et al. Outcomes after repair of complete atrioventricular septal defect. Ann Thorac Surg. 2021;111(6):1802‑1809.
Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic – accessed May 2026.

```